The Online Investor
Stock Splits
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ChartZero.com
ChartZero

Slideshow Stock Splits

By The Online Investor Staff, updated Wed., Jan. 28, 1:27 AM

Slide #2. Cleveland BioLabs, Inc. (NASDAQ:CBLI) 1 for 20 Reverse Split

Announced: 1/27/2015
Stock Split: 1 for 20
Pay Date: 1/28/2015
CBLI Optionable?: No

Cleveland BioLabs is a drug development company engaged in developing pharmaceuticals designed to address diseases with unmet medical need. Co.'s programs are focused on the implementation of pharmacological approaches to control cell death. Entolimod, Co.'s primary product candidate, is a Toll-like receptor five agonist, which it is developing as a radiation countermeasure for prevention of death from Acute Radiation Syndrome and as an oncology drug. Curaxin CBL0137 is Co.'s oncology product candidate. In addition to its Entolimod and CBL0137 development programs, Co. has an additional clinical stage program and several earlier stage development programs.
CBLI Detailed Information Page & Split History »

Company Name:  Cleveland BioLabs Inc
Website:  www.cbiolabs.com
Sector:  Drugs & Pharmaceuticals

Open the CBLI Page at The Online Investor (in a new window) »

January 28, 2015    1:27 AM Eastern
Quotes delayed 20 minutes



Hold (2.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits | www.TheOnlineInvestor.com | Copyright © 1998 - 2015, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.